After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of BioAge Labs Inc is $220.12M. A total of 4.66 million shares were traded on the day, compared to an average of 768.25K shares.
In the most recent transaction, Pande Vijay Satyanand bought 126,793 shares of BIOA for 19.73 per share on Oct 01 ’24. After the transaction, the Director now owns 1,026,793 company shares. In a previous transaction on Oct 02 ’24, Pande Vijay Satyanand bought 67,096 shares at 19.73 per share. BIOA shares that Director owns now total 1,093,889.
Among the insiders who bought shares, Pande Vijay Satyanand acquired of 25,306 shares on Oct 03 ’24 at a per-share price of $19.90. This resulted in the Director holding 1,119,195 shares of BIOA after the transaction. In another insider transaction, Cormorant Asset Management, LP bought 450,000 shares at $18.00 per share on Sep 27 ’24. Company shares held by the Former 10% Owner now total 1,629,529.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BIOA has a high of $26.62 and a low of $3.85.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BIOA is Buy with a score of 2.67.
